# US 2016/0258948 A9 · Methods and compositions of nucleic acid ligands for detection of foodborne and waterborne pathogens

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0258948 A9
- Document ID: US20160258948A9
- Status: Published application
- Kind: A9
- Application number: 13/136,820
- Filed: 2011-08-11
- Published: 2016-09-08
- Earliest claimed: 2008-02-21
- Assignees: Otc Biotechnologies, LLC
- Inventors: John G. Bruno
- Web page: https://patentgrep.com/patent/US20160258948A9

## CPC

- G01N 33/56916: {Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia}
- C12N 15/115: Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith {; Nucleic acids binding to non-nucleic acids, e.g. aptamers}
- C12Q 1/689: for bacteria
- G01N 33/56922: {Campylobacter}
- C12N 2310/16: Aptamers
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Specific DNA sequences for binding various foodborne and waterborne pathogens and biotoxins are described. Each of these sequences can function in varying assay and sensor formats with varying degrees of success.

## Claims

### Claim 1

A DNA ligand sequence consisting of a nucleic acid sequence selected from SEQ ID NOS: 1-650.

### Claim 2 (depends on 1)

A composition comprising the DNA ligand sequence of claim 1.

### Claim 3 (depends on 2)

The composition of claim 2, wherein said aptamer is capable of binding to a targeted waterborne or foodborne pathogenic bacteria.

### Claim 4 (depends on 2)

The composition of claim 2, wherein said aptamer is capable of binding to a targeted waterborne or foodborne pathogenic toxin.

### Claim 5 (depends on 3)

The composition of claim 3, being capable of use for detecting said targeted bacteria, wherein said targeted bacteria is present in a sample with at least 10 bacteria per mL.

### Claim 6 (depends on 3)

The composition of claim 3, being capable of use for quantifying the number of said targeted bacteria in a sample.

### Claim 7 (depends on 1)

The DNA ligand sequence of claim 1, capable of being used for at least one of the assay types: ELISA-like, lateral flow test strip, chemiluminescence, electrochemiluminescence, fluorescence (intensity, lifetime, FP, FRET beacons or competitive FRET), magnetic bead capture, membrane blotting (including dot or slot blotting and the DNA ligand-based analog to “Western” blotting), surface plasmon resonance, plastic-adherent, or radioisotopic detection in food and water samples in tubes, cuvettes or on flat surfaces such as membranes or plastic or glass biochips.

### Claim 8 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is Campylobacter jejuni or a closely related species such as C. coli or C. lari and the DNA ligand sequences are selected from SEQ ID NO's. 1-58.

### Claim 9 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is a pathogenic strain of Escherichia coli and the DNA ligand sequences are selected from SEQ ID NO's. 67-224.

### Claim 10 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is a strain of Listeria monocytogenes or a related species and the DNA ligand sequences are selected from SEQ ID NO's. 279-380.

### Claim 11 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is a strain of Salmonella enterica serovar Typhimurium (formerly Salmonella typhimurium) or a related species and the DNA ligand sequences are selected from SEQ ID NO's. 405-543.

### Claim 12 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is Shiga-like toxin 1 or 2 (or Vero toxins) and the DNA ligand sequences are selected from SEQ ID NO's. 544-612.

### Claim 13 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is a strain of Enterococcus faecalis or a closely related Gram positive organism and the DNA ligand sequences are selected from SEQ ID NO's. 59-66.

### Claim 14 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is Cryptosporidium parvum (or a closely related species) and the DNA ligand sequences are selected from SEQ ID NO's. 613-636.

### Claim 15 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is a species of Giardia parasite and the DNA ligand sequences are selected from SEQ ID NO's. 637-650.

### Claim 16 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is a general Gram negative bacterial pathogen as detected by its lipopolysaccharide (LPS endotoxin) or common core component of LPS and the DNA ligand sequences are selected from SEQ ID NO's. 225-278.

### Claim 17 (depends on 9)

The DNA ligand sequence of claim 9 wherein the target is a general Gram positive bacterial pathogen or a pathogenic or nonpathogenic mold or fungus as detected by its peptidoglycan or chitin or common components such as N-acetyl-glucosamine (NAG) and N-acetylmuramic acid (NAM) and the DNA ligand sequences are selected from SEQ ID NO's. 381-404.

### Claim 18 (depends on 1)

The DNA ligand sequence of claim 1, wherein said nucleic acid sequence is produced by chemical synthesis, wherein said nucleic acid sequence is linear, wherein said nucleic acid sequence has two- or three-dimensional linked multiple aptamers or aptamer binding sites in which said aptamer binding sites have two or more single-stranded segments of 5-10 bases, and wherein intervening nucleotide sequences between said aptamer binding sites do not bind the target.

### Claim 19 (depends on 1)

The DNA ligand sequence of claim 1, wherein said nucleic acid sequence is produced biosynthetically (enzymatically) by polymerase chain reaction (“PCR”), asymmetric PCR, or other DNA polymerase-based reaction using a complementary template DNA into which aptamers or their binding sites are linked with intervening nucleotide sequences that do not bind the target.
